Science Explorer Back to mapMap
Discussion
Researcher · OLVG · Netherlands

Jean‐Paul R. Herrman

Jean‐Paul R. Herrman publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging, on topics such as Coronary Interventions and Diagnostics, Acute Myocardial Infarction Research and Antiplatelet Therapy and Cardiovascular Diseases.

OpenAlex
World rank
#1,008,553
of 7,710,434 ranked researchers
Rank in Netherlands
#23,560
of 107,149
Works
32
Citations
4k
Citations per work
124.4
h-index
15
i10-index 18Top 32% in Cardiology and Cardiovascular Medicine
Jean‐Paul R. Herrman

What does Jean‐Paul R. Herrman research?

Jean‐Paul R. Herrman's work is mostly in Medicine (84%).

Health Sciences: 27 works · 84.2% of their workMedicine: 27 works · 84.2% of their workCardiology and Cardiovascular Medicine: 11 works · 34.8% of their workSurgery: 8 works · 24.7% of their workRadiology, Nuclear Medicine and Imaging: 4 works · 11.2% of their workHematology: 2 works · 6.7% of their workInternal Medicine: 1 works · 3.4% of their workPulmonary and Respiratory Medicine: 1 works · 3.4% of their workEverything else: 5 works · 15.8% of their workTHEIR WORKJean‐Paul R.Herrman32works
Health Sciences84%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2784.2%
  2. Everything else515.8%
  1. 1Cardiology and Cardiovascular Medicine35% of their works
  2. 2Surgery25% of their works
  3. 3Radiology, Nuclear Medicine and Imaging11% of their works
  4. 4Hematology7% of their works
  5. 5Internal Medicine3% of their works
  6. 6Pulmonary and Respiratory Medicine3% of their works

Research topics

Which keywords describe Jean‐Paul R. Herrman's research?

The keywords of their largest research topics: Percutaneous Coronary Intervention, Myocardial Infarction, Guidelines, Coronary Stents, Myocardial Revascularization, Acute Coronary Syndromes, ST-Segment Elevation and Aspirin.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Percutaneous Coronary Intervention272 topics
  2. Myocardial Infarction232 topics
  3. Guidelines172 topics
  4. Coronary Stents161 topic
  5. Myocardial Revascularization161 topic
  6. Acute Coronary Syndromes131 topic
  7. ST-Segment Elevation131 topic
  8. Aspirin111 topic
  9. Clopidogrel111 topic
  10. Cardiac Imaging101 topic
  11. Coronary Artery Disease101 topic
  12. Anticoagulant Therapy41 topic
  13. Atrial Fibrillation41 topic
  14. Platelets41 topic
  15. Thrombosis41 topic
  16. Antithrombotic Therapy31 topic
  17. Venous Thromboembolism31 topic
  18. Matrix Metalloproteinases21 topic
  19. Tissue Inhibitors of Metalloproteinases21 topic

Where does Jean‐Paul R. Herrman work?

Jean‐Paul R. Herrman's main affiliation in the publication record is OLVG, Netherlands.

How many publications and citations does Jean‐Paul R. Herrman have?

OpenAlex counts 32 works and 3,980 citations for Jean‐Paul R. Herrman, an h-index of 15, ranking #1,008,553 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jean‐Paul R. Herrman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.